Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc ICOTF


Primary Symbol: T.MSCL Alternate Symbol(s):  MSCLF

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).


TSX:MSCL - Post by User

Comment by Goldy63on Jul 17, 2018 11:31am
113 Views
Post# 28326982

RE:RE:Mr reda!!

RE:RE:Mr reda!!
KeepGoing wrote: Looks like shorters have failed to drive the price to single digits and the price has now bottomed out.

They will be desperate to cover their positions and that in itself will push the price up.  

If we take even a 3-6 month view, this blip will be seen for what it is.

Personally, I think 12-18 month view on this stock is better.  More catalysts will come to fruition during this period and the stock will find much higher floors. 

Shorters will still meddle with the price but with a medium term view what they do does not really matter.  
Agreed . Ground floor with plenty of catalyts coming and the best time to hold a stack and accumulate as sp gains ground and momentum . Going to get more expensive soon enough . JMO. Cheers . 

<< Previous
Bullboard Posts
Next >>